Possibilities of using meldonium in the treatment of subacute and chronic forms of cerebrovascular accident
The article discusses the issue of cytoprotective therapy for chronic and subacute cerebral circulatory failure, the potential role of Meldonium in the correction of cognitive, emotional, and motor disorders in patients with cerebrovascular diseases, and provides an overview of modern clinical studies of the effectiveness of Meldonium in chronic subacute cerebral ischemia.Prokopenko S.V., Koryagina T.D.
Keywords
cerebrovascular disease
chronic cerebral ischemia
ischemic stroke
cytoprotective therapy
meldonium
About the Authors
Corresponding author: Semyon V. Prokopenko, Dr. Sci. (Med.), Prof., Head of the Department of Nervous Diseases with a Course of Postgraduate Education, Professor at the Department of Physical and Rehabilitation Medicine with a Course of Postgraduate Education, Krasnoyarsk State Medical Universityn.a. Professor V.F. Voino-Yasenetsky, Krasnoyarsk, Russias.v.proc.58@mail.ru